Budget Impact Analysis of Hypertonic Saline Inhalations for Infant Bronchiolitis: The Colombian National Health System Perspective

ABSTRACT: Objectives: Nebulized 3% hypertonic solution (HS) is associated with lower total cost and higher quality-adjusted life-years. Nevertheless, the expected budget impact of this drug had not been explicitly estimated. The aim of this study was to evaluate the budget impact of 3% HS in the tre...

Full description

Autores:

Buendía Rodríguez, Jefferson Antonio
Guerrero Patiño, Diana

Tipo de recurso:

Article of investigation

Fecha de publicación:

2022

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/45314

Acceso en línea:

https://hdl.handle.net/10495/45314

Palabra clave:

Análisis de Impacto Presupuestario de Avances Terapéuticos
Analysis of the Budgetary Impact of Therapeutic Advances
Bronquiolitis - tratamiento farmacológico
Bronchiolitis - drug therapy
Soluciones Hipertónicas - uso terapéutico
Hypertonic Solutions - therapeutic use
Terapia Respiratoria
Respiratory Therapy
Nebulizadores y Vaporizadores
Nebulizers and Vaporizers
Lactante
Infant
Colombia
Broncodilatadores - uso terapéutico
Bronchodilator Agents - therapeutic use
https://id.nlm.nih.gov/mesh/D001988
https://id.nlm.nih.gov/mesh/D006982
https://id.nlm.nih.gov/mesh/D012138
https://id.nlm.nih.gov/mesh/D009330
https://id.nlm.nih.gov/mesh/D007223
https://id.nlm.nih.gov/mesh/D003105
https://id.nlm.nih.gov/mesh/D001993

Rights

openAccess

License

http://creativecommons.org/licenses/by-nc-nd/2.5/co/